Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia

Overview of attention for article published in American Journal of Hematology, September 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
twitter: 39 X users

guideline: 1 clinical guideline source

Readers on

mendeley: 24 Mendeley

So far, Altmetric has seen 50 X posts from 39 X users, with an upper bound of 120,824 followers.

RT @SCTNB: Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia https:/…

Differential prognostic impact of RUNX1 mutations according to frontline therapy in patients with acute myeloid leukemia https://t.co/BTJm3x8E5O

RT @AjHematology: The prognostic impact of RUNX1 mutations in AML may be treatment-dependent; RUNX1 mutations may not adversely impact outc…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 46 additional X posts.